Objective: The size (number of women screened) of the 95 individual NHS breast screening programmes (NHSBSPs) varies by a factor of 10. This study investigates the impact of size on the performance of individual programmes. Method: Data were collated from the 95 United Kingdom screening programmes on the standard statistical returns for the past 5 years (1 April 1995-31 March 2000. Additional information was obtained from questionnaires. The number of women screened between 1 April 1999 and 31 March 2000 determined the size of a programme. The bottom 25% were defined as small, the middle 50% as medium, and the top 25% as large. On average large programmes screened about four times as many women as small programmes and medium programmes about twice as many. Performance was evaluated using cancer detection rates, referral rates for assessment, and positive predictive value (PPV) of assessment using PPV referral diagrams. Results: The performance of smaller programmes was shown to be marginally poorer than medium and large sized programmes in that they detected fewer cancers and had a lower PPV. The smallest 25% of programmes had an invasive cancer detection rate 13% less than the medium and large programmes. However, if these programmes had an equivalent detection rate to the medium/large programmes the national detection rate would only increase by about 2%. This is because the 75% of programmes described as medium and large screen about 90% of all women. It is therefore important to place the clinical importance of these findings in context when considering any envisaged possible solutions. Conclusions: Although the performance of smaller programmes was shown to be poorer than that of the larger programmes, it is not clear from this study exactly why this is so. A likely contributory factor based on experience of evaluating the NHSBSP is that performance problems in larger programmes have been easier to detect by quality assurance staff. The size of the small programmes and the few screen detected cancers (and inherent statistical instability in detection rates) mean that problems are difficult to identify. As a consequence small programmes which are genuinely performing marginally below specific standards are likely to receive less attention than larger programmes, and even under close scrutiny the causes are less likely to be found.
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T he United Kingdom National Health Service breast screening programme (NHSBSP) was started in 1988 following the recommendations of the Forrest Report. 1 A basic screening unit was defined as covering a population of 41 150 women aged 50-64, this figure being known as a "Forrest unit". Each year a Forrest unit sized programme would invite 13 716 women of whom 9600 would be expected to attend assuming a 70% uptake. Following the implementation of the report the actual screening programmes varied in size considerably, although the average is about a Forrest unit.
The variation in programme size, defined in terms of the number of women aged 50-64 screened at prevalent and incident screens in the year 1 April 1999 to 31 March 2000, is shown in table 1. The median number of screened women was 11 747 and the range was 3454-33 243, a factor of 10. Assuming a 70% uptake these figures correspond to populations of 0.36-3.43 Forrest units. This study investigates whether there is any difference in screening programme performance that relates to the size of the individual programme.
METHODS
Information on the numbers of screened women and cancers detected were taken from the annual KC62 return forms completed by each of the 95 screening programmes in England, Scotland, Wales, and Northern Ireland. Additional information on screening protocols relating to number of views and film readers was obtained from questionnaires. Analysis of detection rates uses both the crude cancer detection rate and the age standardised "standardised detection ratio" (SDR). The SDR compares sensitivity for the detection of invasive cancers with the equivalent that would have been achieved by the Swedish Two County Randomised Controlled Trial, 2 an SDR of 1 indicating parity with this trial. The quality of screening has been measured using the PPV referral diagram, which plots the PPV of referral (the percentage of women referred for assessment with a final diagnosis of cancer (PPV%)) against the percentage of women referred for assessment. 3 The cancer detection rate is given as isobars on the diagram. The PPV referral diagrams use data for women aged 50-64 for prevalent and incident screens combined. The NHSBSP is now in a steady state where most women are screened aged 50-52 for prevalent screens, and 53-64 for incident screens. With nearly all programmes performing about two incident screens for each prevalent screen it is reasonable to use the total numbers of women screened, referred, and cancers detected from these screens. The resulting data are reasonably statistically stable when looking at individual programmes, and this consideration outweighs any very small amount of confounding. This was not true in the early years of the screening programme (before 1995-6), where confounding by age was a major issue.
Small programmes have been defined as the bottom 25% of programmes based on the number of women screened aged 50-64 for prevalent and incident screens, in the screening year 1 April 1999 to 31 March 2000. Medium programmes have been defined as the middle 50% and large programmes as the top 25%. With 95 programmes in total, there are 24 small programmes, 47 medium, and 24 large. The median number of women screened was 5657, 11 747, and 22 165 respectively, a ratio of about 1:2:4 in size. The 25% cut off points were chosen to give three reasonable groupings while maintaining sufficient numbers of small programmes to give statistically reliable measures of performance with data from 1 year for the programmes defined as small. Table 2 and figure 1 show the data for the most recent screening year. The small programmes have the lowest PPV (9.97%) and the highest referral rate (5.15%) suggesting a lower quality of screening at these programmes. The SDR (corrected for background incidence) for the small programmes was 1.00 compared with 1.14 for medium programmes and 1.16 for large programmes, suggesting about a 15% increase in the age standardised detection rate of invasive cancer for medium and large programmes compared with small programmes.
RESULTS

Most recent screening year 1 April 1999 to 31 March 2000
To determine whether the poorer performance of small programmes was related to the number of film readers or views taken, the data were examined stratified by these further variables. Table 3 shows the number of film readers by programme size, not including the seven programmes that used two views for all screens. Table 3 also includes information on detection rates from SDRs. With the exception of the four programmes that used double reading with arbitration, small programmes had lower SDRs for the other reading protocols. The most likely explanation is that the low SDRs are not related to number of film readers, but may be to some other function of small programmes.
Past 5 screening years 1 April 1995 to 31 March 2000
Further analysis has been conducted to find whether the poorer performance of the small programmes was a recent finding or whether this has been the case for the past 5 years. With the 5 year aggregated data, table 4 and figure 2 show that the PPV from small programmes (9.8%) was lower than that from large (11.1%) or medium programmes (11.3%). The referral rate of smaller programmes (5.01%) was very marginally higher than that from large (4.96%) and medium programmes (4.74%). The combination of PPV and referral rates suggests a lower performance from the small programmes over the 5 year period. All three sizes of programmes showed improvements in screening performance over the past 5 years with increases in PPV and detection rates over the period (although part of the improvement in detection rates was simply due to increased referral rates). For the past 2 screening years the referral rates for all three sizes of programmes were similar, but the PPV of referral was about 15% higher for the medium and large programmes. For the small programmes 1 in 10 referred women had a final diagnosis of cancer, but for medium and large programmes it was better than 1 in 9 women.
DISCUSSION
The results given in this paper suggest that performance as measured by PPV of assessment and cancer detection rates is marginally poorer in small screening programmes than medium or large sized programmes. The performance of medium and large programmes was similar. It is not clear what function of staff, training, equipment, or screening protocol explains these findings.
Some of the improvements of the national programme in the past 10 years have been due to the identification of a few larger programmes with very low rates of detection of invasive cancer (SDRs). After investigation and the detection of specific problems, these programmes have shown substantial improvements and have clearly shown that the NHSBSP is able to identify and correct performance in many cases. However, for small programmes it is difficult for quality assurance staff to detect potential underperformance because of statistical instability from relatively small numbers. Table 5 shows one such example based on the SDR results for the past 3 years. The SDR for prevalent screens showed great variability each year, the programme was near to the top some years and the bottom in other years when the 95 programmes in the NHSBSP were ranked in a "league table". The 90% confidence interval (90% CI) around the 3 year combined prevalent screen SDR of 0.93 was 0.60 to 1.44. Thus even with 3 years prevalent screen data we cannot tell if this is one of the worst or best programmes or just average. Combining data for prevalent and incident screens over 3 years we have an SDR of 0.82 (90% CI 0.65 to 1.04). Even with the combined data for 3 years it is not possible to tell if this programme is underperforming (defined by the NHSBSP as an SDR<0.75). If the programme were 10 times larger with 470 observed cancers and 572.2 expected, the SDR would be 0.82 (90% CI 0.76 to 0.89). A programme with these results, although not technically underperforming, would almost certainly be of concern to quality assurance staff as it is clearly well below the target SDR of 1. These arguments suggest that small programmes can escape detailed quality assurance measures. Of the 24 small programmes there may be two or three with unknown screening quality issues which have escaped detection, which could explain the marginally poorer screening performance of the smaller programmes.
An alternative, although not mutually exclusive hypothesis is that radiologists at small programmes are on average less skilled at film reading, than at larger programmes, because they read fewer films a year. Studies have shown evidence that film reading skill is related to the number of mammograms read a year, 4 5 however, these studies have examined relatively few mammograms read a year compared with the numbers read by film readers in the NHSBSP.
Although no specific problem with smaller programmes has been identified, an obvious solution could be for small programmes to merge with medium or larger programmes. It is informative to discuss the overall benefit to the NHSBSP if such mergers did take place and assuming that detection rates were improved. The overall impact on the detection rate of the NHSBSP for invasive cancer is shown in table 6. If small programmes increased their SDR from 1.02 to 1.16, the overall national SDR would increase from 1.14 to 1.16. The number of invasive cancers detected would increase by 73 from 5795 to 5868, a relatively small increase. This is because the smallest 25% of programmes only screen about 10% of the population, so even a relatively large improvement in performance of these programmes will only have a modest impact nationally. Furthermore, many of the smaller programmes are in rural areas and if women were deterred from attending, because of having to travel further distances, then the overall benefit to the NHSBSP could be further reduced.
The NHSBSP may have already partly solved the problem of small programmes by the invitation of women aged 65-70 over the coming years. Assuming that the number of programmes stays the same, then many (about one third) of the small programmes will effectively become medium sized as they will be screening more women a year. Any underperformance by these programmes will consequently become easier to detect. By monitoring the performance of the programmes defined in this paper as small, medium, and large, over the next few years, we should be able to detect whether there is a narrowing in the relative performance between them.
In summary, this paper presents evidence that on average small programmes may be marginally performing less well than bigger programmes, closer to the size originally envisaged by the Forrest report or larger. The reasons for this are unclear, but could be related to individual film reading skill or the ability of quality assurance techniques to adequately detect poorer performance in small programmes. 
